Reda Bouabdallah Selected Research

BEAM regimen

1/2020	Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers.
12/2014	Upfront consolidation combining yttrium-90 ibritumomab tiuxetan and high-dose therapy with stem cell transplantation in poor-risk patients with diffuse large B cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Reda Bouabdallah Research Topics

Disease

16	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 05/2002
15	Lymphoma (Lymphomas) 01/2022 - 01/2005
14	Neoplasms (Cancer) 01/2022 - 06/2003
14	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2021 - 01/2002
11	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 01/2005
9	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2021 - 09/2008
6	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 03/2010
6	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020 - 03/2010
5	Multiple Myeloma 05/2013 - 12/2003
4	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021 - 10/2012
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 12/2005
4	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 12/2010
2	Fatigue 01/2021 - 01/2020
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2021 - 03/2016
2	Disease Progression 07/2020 - 01/2020
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2020 - 03/2015
2	Bronchiolitis Obliterans Syndrome 01/2018 - 03/2014
2	Febrile Neutropenia 01/2018 - 08/2016
2	Neutropenia 01/2018 - 08/2017
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 06/2017 - 02/2013
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2017 - 10/2014
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2016 - 07/2004
2	Hematologic Diseases (Blood Diseases) 06/2015 - 01/2015
1	Anemia 01/2021
1	Inflammation (Inflammations) 01/2020
1	Infertility (Sterility) 01/2019
1	Breast Neoplasms (Breast Cancer) 12/2016
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2016
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 12/2016
1	Mycoses (Diseases, Fungus) 01/2015
1	Aspergillosis 01/2015
1	Invasive Fungal Infections 01/2015
1	Pathologic Complete Response 12/2014
1	Body Weight (Weight, Body) 01/2013
1	Circulating Neoplastic Cells 10/2012

Drug/Important Bio-Agent (IBA)

18	Rituximab (Mabthera)FDA Link 08/2019 - 01/2002
12	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2002
10	Lenalidomide (CC 5013)FDA Link 01/2022 - 09/2010
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2002
7	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 01/2002
6	Prednisone (Sone)FDA LinkGeneric 01/2019 - 01/2002
5	obinutuzumabIBA 01/2022 - 08/2013
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 07/2015
3	BI 836826IBA 02/2021 - 10/2020
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 12/2014
3	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 12/2014
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2005
3	Brentuximab VedotinIBA 11/2019 - 03/2015
3	Monoclonal AntibodiesIBA 08/2013 - 01/2002
2	Vinblastine (Vinblastine Sulfate)FDA Link 01/2022 - 01/2019
2	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 01/2019
2	selinexorIBA 04/2021 - 07/2020
2	3- (5- amino- 2- methyl- 4- oxoquinazolin- 3(4H)- yl)piperidine- 2,6- dioneIBA 09/2020 - 01/2020
2	Melphalan (Alkeran)FDA LinkGeneric 01/2020 - 12/2014
2	Carmustine (FIVB)FDA Link 01/2020 - 12/2014
2	Chlorambucil (Leukeran)FDA Link 06/2017 - 02/2013
2	abexinostatIBA 01/2017 - 01/2016
2	Histone Deacetylase InhibitorsIBA 01/2017 - 01/2016
2	Dexamethasone (Maxidex)FDA LinkGeneric 08/2016 - 09/2010
2	thymoglobulin FDA Link 01/2014 - 12/2010
2	Busulfan (Busulfex)FDA Link 01/2014 - 12/2010
2	CytokinesIBA 12/2005 - 05/2002
2	Messenger RNA (mRNA)IBA 01/2005 - 05/2002
1	Alanine Transaminase (SGPT)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	tremelimumabIBA 01/2021
1	danvatirsenIBA 01/2021
1	durvalumabIBA 01/2021
1	AntibodiesIBA 09/2020
1	Bendamustine Hydrochloride FDA Link 01/2020
1	Procarbazine (Matulane)FDA Link 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 08/2016
1	CreatinineIBA 08/2016
1	Immunoconjugates (Immunoconjugate)IBA 03/2015
1	Fluconazole (Zonal)FDA LinkGeneric 01/2015
1	Itraconazole (Sporanox)FDA LinkGeneric 01/2015
1	Micafungin (FK463)FDA Link 01/2015
1	ibritumomab tiuxetan (Zevalin)FDA Link 12/2014
1	Yttrium-90IBA 12/2014
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 03/2014
1	fludarabineIBA 01/2014
1	Bortezomib (Velcade)FDA Link 03/2013
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2010

Therapy/Procedure

27	Stem Cell Transplantation 01/2022 - 12/2003
16	Therapeutics 01/2022 - 05/2002
15	Drug Therapy (Chemotherapy) 01/2022 - 01/2002
9	Transplantation 01/2021 - 01/2011
8	Hematopoietic Stem Cell Transplantation 01/2018 - 06/2012
4	Haploidentical Transplantation 11/2020 - 01/2018
2	Induction Chemotherapy 01/2020 - 07/2004
2	BEAM regimen 01/2020 - 12/2014
2	Breast Implants (Breast Implant) 01/2020 - 01/2020
2	Immunotherapy 01/2018 - 01/2018
2	Radiotherapy 04/2014 - 01/2014
2	Salvage Therapy 07/2012 - 12/2008
1	Combination Drug Therapy (Combination Chemotherapy) 01/2018
1	Autologous Transplantation 01/2018
1	Aftercare (After-Treatment) 12/2016
1	Chemoradiotherapy 08/2016
1	Intravenous Administration 06/2014